Global Biologics Market Size & Outlook, 2024-2030
Global biologics market, 2018-2030 (US$M)
Related Markets
Global biologics market highlights
- The global biologics market generated a revenue of USD 400,029.3 million in 2024 and is expected to reach USD 653,347.4 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 8.5% by 2030.
- In terms of segment, monoclonal antibodies (mabs) accounted for a revenue of USD 276,054.2 million in 2024.
- Antisense & RNAi Therapeutics is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Canada is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 400,029.3 million |
| Market revenue in 2030 | USD 653,347.4 million |
| Growth rate | 8.5% (CAGR from 2025 to 2030) |
| Largest segment | Monoclonal antibodies (mabs) |
| Fastest growing segment | Antisense & RNAi Therapeutics |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monoclonal antibodies (MABs), Vaccines, Recombinant Proteins, Antisense & RNAi Therapeutics |
Other key industry trends
- In terms of revenue, the North America accounted for 54.7% of the global biologics market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Canada is the fastest growing regional market and is projected to reach USD 41,805.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biologics Market Scope
Biologics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global biologics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biologics market will help companies and investors design strategic landscapes.
Monoclonal antibodies (mabs) was the largest segment with a revenue share of 69.01% in 2024. Horizon Databook has segmented the Global biologics market based on monoclonal antibodies (mabs), vaccines, recombinant proteins, antisense & rnai therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Biologics Product Outlook (Revenue, USD Million, 2018-2030)
- Monoclonal antibodies (MABs)
- Vaccines
- Recombinant Proteins
- Antisense & RNAi Therapeutics
- Others
- Global Biologics Disease Category Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- Immunological Disorders
- Infectious diseases
- Ophthalmology
- Pre-filled syringes
- Other Delivery System
- Cardiovascular Disorders
- Hematological Disorders
- Others
- Global Biologics Dosage Form Outlook (Revenue, USD Million, 2018-2030)
- Injectable Dosage Forms
- Prefilled Syringes
- Vials
- Others
- Others
- Injectable Dosage Forms
Reasons to subscribe to Global biologics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global biologics market databook
-
Our clientele includes a mix of biologics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global biologics market , including forecasts for subscribers. This global databook contains high-level insights into Global biologics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global biologics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Biologics market size, 2024 (US$M)
Global biologics market share, by product, 2024 & 2030 (%, US$M)
Biologics market: Opportunity assessment by country
Global biologics market, by region, 2024 (US$M)
| Product | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 138,366.9 | 141,782.4 | 140,544.8 | 183,077.2 | 210,070.8 | 208,608.3 | 218,845.1 | 231,916.2 | 248,272.5 | 267,384.9 | 289,563.1 | 314,289.5 | 342,663.9 | 7.8% |
| Europe | 54,874.5 | 63,390.6 | 70,295.6 | 90,756.5 | 98,584.2 | 102,276.4 | 104,437.9 | 111,555.8 | 120,336.6 | 130,652.8 | 142,979.3 | 156,772.9 | 172,696.5 | 8.7% |
| Asia Pacific | 31,676.9 | 35,202.6 | 39,302.6 | 66,086.4 | 56,926.6 | 53,765.6 | 59,964.4 | 65,336.6 | 71,879.2 | 79,534.9 | 88,530.1 | 98,720.8 | 110,546.4 | 10.7% |
| Latin America | 5,399.9 | 5,814.8 | 6,097.1 | 8,348.3 | 9,046.8 | 9,092.4 | 9,628.8 | 10,349.2 | 11,236.1 | 12,274.9 | 13,495.0 | 14,869.1 | 16,464.4 | 9.4% |
| MEA | 4,460.8 | 4,719.3 | 4,861.6 | 6,539.9 | 6,962.8 | 6,875.2 | 7,153.2 | 7,553.5 | 8,057.0 | 8,647.5 | 9,340.4 | 10,111.0 | 10,976.2 | 7.4% |
| Overall | 234,779.0 | 250,909.8 | 261,101.6 | 354,808.2 | 381,591.3 | 380,617.8 | 400,029.3 | 426,711.2 | 459,781.4 | 498,495.0 | 543,907.8 | 594,763.2 | 653,347.4 | 8.5% |
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
